Page last updated: 2024-12-07
2,3-epoxysuccinic acid
Description
2,3-Epoxysuccinic acid, also known as maleic acid epoxide, is a cyclic anhydride of tartaric acid. It is a white, crystalline solid that is soluble in water. 2,3-Epoxysuccinic acid is a versatile synthetic intermediate, used in the production of various organic compounds including pharmaceuticals, polymers, and agricultural chemicals. It has been studied for its potential applications in organic synthesis, particularly in the preparation of chiral molecules. Its reactivity towards nucleophiles and its ability to undergo ring-opening reactions make it a valuable reagent in organic chemistry.'
2,3-epoxysuccinic acid: RN given refers to parent cpd with unspecified isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 86022 |
| CHEMBL ID | 2008310 |
| SCHEMBL ID | 253521 |
| MeSH ID | M0067959 |
Synonyms (26)
| Synonym |
|---|
| NSC43234 , |
| nsc243799 |
| 3272-11-5 |
| nsc-243799 |
| 2,3-oxiranedicarboxylic acid |
| NCI60_004002 |
| 6311-64-4 |
| einecs 240-604-3 |
| ccris 3757 |
| cis-2,3-epoxysuccinic acid |
| 2,3-oxiranedicarboxylic acid, cis- |
| epoxysuccinic acid |
| 2,3-epoxysuccinic acid |
| oxirane-2,3-dicarboxylic acid |
| nsc 243799 |
| einecs 221-900-1 |
| FT-0623894 |
| FT-0605454 |
| SCHEMBL253521 |
| AKOS022504512 |
| DCEMCPAKSGRHCN-UHFFFAOYSA-N |
| epoxy-succinic acid |
| CHEMBL2008310 |
| AS-59308 |
| DTXSID50901492 |
| D94020 |
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.25
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.25 (24.57) | | Research Supply Index | 2.20 (2.92) | | Research Growth Index | 4.45 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |